Therapeutic Asset Ratings
329 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Iodixanol
Obesity
Yale University
D
(26)
Ipilimumab
Obesity
Universitaire Ziekenhuizen KU Leuven
N/A
D
(26)
Iron
Obesity Disorder
Cairo University
D
(26)
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Obesity Disorder
Linda Malan
N/A
D
(26)
Iron Isomaltoside
Obesity Disorder
China-Japan Friendship Hospital
N/A
D
(26)
Lactate
Obesity Disorder
Rutgers, The State University of New Jersey
N/A
D
(26)
LACTULOSE
Obesity
Yale University
D
(26)
L-AMINO ACIDS
Obesity Disorder
Bioagile Therapeutics Pvt. Ltd.
N/A
D
(26)
Leap-2 Protein, Human
Obesity Disorder
University Hospital, Gentofte, Copenhagen
N/A
D
(26)
LENVATINIB
Obesity
Universitaire Ziekenhuizen KU Leuven
N/A
D
(26)
Maltodextrin
Obesity Disorder
Virginia Polytechnic Institute and State University
N/A
D
(26)
MANNITOL
Obesity Disorder
Pichamol Jirapinyo, MD, MPH
D
(26)
METARAMINOL
Obesity
Fundació d'investigació Sanitària de les Illes Balears
N/A
D
(26)
Midodrine
Obesity
Fundació d'investigació Sanitària de les Illes Balears
N/A
D
(26)
Nivolumab
Obesity
Universitaire Ziekenhuizen KU Leuven
N/A
D
(26)
NORADRENALINE TARTRATE IMPURITY C
Obesity
Fundació d'investigació Sanitària de les Illes Balears
N/A
D
(26)
Oxalic Acid
Obesity
University of Alabama at Birmingham
N/A
D
(26)
Oxycodone
Obesity Disorder
Göteborg University
N/A
D
(26)
Pembrolizumab
Obesity
Universitaire Ziekenhuizen KU Leuven
N/A
D
(26)
Potato Starch
Obesity Disorder
Purdue University
N/A
D
(26)
S-Ketamine
Obesity Disorder
Göteborg University
N/A
D
(26)
SUNFLOWER OIL
Obesity Disorder
Nantes University Hospital
N/A
D
(26)
TACROLIMUS
Obesity
Larissa University Hospital
N/A
D
(26)
Walnut oil
Obesity Disorder
University of Illinois at Urbana-Champaign
N/A
D
(26)
WHOLE WHEAT ALLERGENIC EXTRACT
Obesity Disorder
University of Toronto
N/A
D
(26)
Showing 301 to 325 of 329 assets
Previous
Page 13 of 14
Next